Research presented at the Conference on Retroviruses and Opportunistic Infections details the success of sofosbuvir/ledipasvir therapy in individuals with both HIV and hepatitis C infection.
A multicenter phase 1/2 trial evaluated the acceptability and tolerability of long-acting injectable cabotegravir–rilpivirine over 48 weeks in adolescents with HIV-1, focusing on patient-reported pain,...
In February 2025, the Department of Health and Human Services announced a plan to overhaul its functions and consolidate resources. Since that announcement, workforce cuts, legal battles, and partial...
A new analysis of US claims data examined preexposure prophylaxis prescribing patterns among commercially insured adolescents and young adults at increased risk for HIV, offering clinicians insights into...
A new study examined the relationship between the use of opioids and increased risk for hospitalizations due to serious infections among rheumatoid arthritis patients.
